Compare Unichem Lab with Jubilant Pharmova - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs JUBILANT PHARMOVA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB JUBILANT PHARMOVA UNICHEM LAB/
JUBILANT PHARMOVA
 
P/E (TTM) x -47.7 14.5 - View Chart
P/BV x 1.2 2.7 43.3% View Chart
Dividend Yield % 1.2 0.6 214.8%  

Financials

 UNICHEM LAB   JUBILANT PHARMOVA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
JUBILANT PHARMOVA
Mar-19
UNICHEM LAB/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs292898 32.5%   
Low Rs182618 29.5%   
Sales per share (Unadj.) Rs167.7572.0 29.3%  
Earnings per share (Unadj.) Rs-3.636.2 -10.0%  
Cash flow per share (Unadj.) Rs5.959.5 10.0%  
Dividends per share (Unadj.) Rs4.004.50 88.9%  
Dividend yield (eoy) %1.70.6 284.2%  
Book value per share (Unadj.) Rs372.3301.9 123.3%  
Shares outstanding (eoy) m70.38159.28 44.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.41.3 106.7%   
Avg P/E ratio x-65.320.9 -312.1%  
P/CF ratio (eoy) x39.912.7 313.3%  
Price / Book Value ratio x0.62.5 25.4%  
Dividend payout %-110.212.4 -886.9%   
Avg Mkt Cap Rs m16,680120,694 13.8%   
No. of employees `0002.62.4 108.9%   
Total wages/salary Rs m2,39319,260 12.4%   
Avg. sales/employee Rs Th4,535.238,120.6 11.9%   
Avg. wages/employee Rs Th919.88,058.4 11.4%   
Avg. net profit/employee Rs Th-98.22,414.3 -4.1%   
INCOME DATA
Net Sales Rs m11,80191,108 13.0%  
Other income Rs m984357 275.3%   
Total revenues Rs m12,78591,466 14.0%   
Gross profit Rs m-83517,390 -4.8%  
Depreciation Rs m6743,709 18.2%   
Interest Rs m752,198 3.4%   
Profit before tax Rs m-60011,840 -5.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m-3433,268 -10.5%   
Profit after tax Rs m-2565,770 -4.4%  
Gross profit margin %-7.119.1 -37.1%  
Effective tax rate %57.327.6 207.5%   
Net profit margin %-2.26.3 -34.2%  
BALANCE SHEET DATA
Current assets Rs m20,38445,848 44.5%   
Current liabilities Rs m5,02920,897 24.1%   
Net working cap to sales %130.127.4 475.1%  
Current ratio x4.12.2 184.7%  
Inventory Days Days10557 184.5%  
Debtors Days Days13551 264.8%  
Net fixed assets Rs m9,02365,498 13.8%   
Share capital Rs m141159 88.4%   
"Free" reserves Rs m26,05847,930 54.4%   
Net worth Rs m26,19948,089 54.5%   
Long term debt Rs m042,429 0.0%   
Total assets Rs m31,496114,685 27.5%  
Interest coverage x-7.06.4 -109.2%   
Debt to equity ratio x00.9 0.0%  
Sales to assets ratio x0.40.8 47.2%   
Return on assets %-0.66.9 -8.2%  
Return on equity %-1.012.0 -8.1%  
Return on capital %-2.012.4 -16.1%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18812,422 65.9%   
Fx outflow Rs m59617,227 3.5%   
Net fx Rs m7,592-4,805 -158.0%   
CASH FLOW
From Operations Rs m-3,27811,215 -29.2%  
From Investments Rs m-2,860-10,118 28.3%  
From Financial Activity Rs m-246,574 -0.4%  
Net Cashflow Rs m-4,6907,612 -61.6%  

Share Holding

Indian Promoters % 50.1 45.6 109.9%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 15.1 8.7 173.6%  
FIIs % 3.0 21.2 14.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 21.1 150.2%  
Shareholders   20,176 23,815 84.7%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  NOVARTIS  FULFORD INDIA  ORCHID PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Recover From Day's Low to End Strong; JSW Steel and ICICI Bank Among Top Nifty Gainers(Closing)

Indian share markets recouped early losses during afternoon deals and ended today's volatile session higher.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Apr 22, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS